RecruitingNot ApplicableNCT05415384

Randomized Control Trial, Cryoablation as an Adjunct to Surgical Stabilization of Rib Fractures

Single Center, Randomized Control Trial of Cryoablation During Surgical Stabilization of Rib Fractures


Sponsor

Wake Forest University Health Sciences

Enrollment

80 participants

Start Date

Aug 1, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

To determine if patients with intraoperative cryoablation have better analgesia results compared to the control group of Surgical Stabilization of Rib Fractures (SSRF) without cryoablation


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Cryoablation of Intercostal Nerves and a procedure called Standard surgical treatment of patients with multiple rib fractures for people with pain, postoperative and rib fracture multiple. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICECryoablation of Intercostal Nerves

Using Atricure device, cryoice, intercostal nerves 3-8 will be ablated in the experimental arm. This is in addition to mechanical fixation of rib fractures and multimodal systemic therapy.

PROCEDUREStandard surgical treatment of patients with multiple rib fractures

Standard surgical treatment of patients with multiple rib fractures


Locations(1)

Wake Forest University Health Sciences

Winston-Salem, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05415384


Related Trials